Curis
CRIS
#10981
Rank
โ‚ฌ0.59 M
Marketcap
0,30ย โ‚ฌ
Share price
-17.89%
Change (1 day)
-79.71%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -โ‚ฌ29.24 Million

According to Curis's latest financial reports the company's current earnings are โ‚ฌ11.65 Million. In 2024 the company made an earning of -โ‚ฌ37.47 Million, an increase over its 2023 earnings that were of -โ‚ฌ39.76 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ29.24 Million-21.97%
2024 -โ‚ฌ37.47 Million-5.77%
2023 -โ‚ฌ39.76 Million-13.1%
2022 -โ‚ฌ45.75 Million27.52%
2021 -โ‚ฌ35.88 Million65.09%
2020 -โ‚ฌ21.74 Million-9.1%
2019 -โ‚ฌ23.91 Million-4.73%
2018 -โ‚ฌ25.1 Million-41.95%
2017 -โ‚ฌ43.23 Million-14.37%
2016 -โ‚ฌ50.48 Million3.55%
2015 -โ‚ฌ48.75 Million271.52%
2014 -โ‚ฌ13.13 Million76.64%
2013 -โ‚ฌ7.43 Million
2011 -โ‚ฌ6.31 Million27.76%
2010 -โ‚ฌ4.94 Million-43.87%
2009 -โ‚ฌ8.8 Million-23.44%
2008 -โ‚ฌ11.5 Million56.66%
2007 -โ‚ฌ7.34 Million-16.71%
2006 -โ‚ฌ8.81 Million-36.92%
2005 -โ‚ฌ13.96 Million156.25%
2004 -โ‚ฌ5.45 Million-37.24%
2003 -โ‚ฌ8.69 Million-93.34%
2002 -โ‚ฌ0.14 Billion86.79%
2001 -โ‚ฌ69.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ9.27 B-32,629.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ8.40 B-29,576.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚ฌ54.2 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚ฌ0.87 B-3,181.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚ฌ0.26 Billion 782.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚ฌ21.69 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.14 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA